Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue

Loading...
Loading...
Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Forest Laboratories
FRX
is $3.82 billion. Forest Laboratories' ROE for the same period is 9.98%. The trailing-twelve-month revenue at Endo Health Solutions
ENDP
is $3.03 billion. Endo Health's PEG ratio is 0.90. The trailing-twelve-month revenue at Warner Chilcott plc
WCRX
is $2.58 billion. Warner Chilcott had $304.00 million in total cash for the latest quarter. The trailing-twelve-month revenue at Dr. Reddy's Laboratories
RDY
is $2.05 billion. Dr. Reddy's operating margin for the same period is 20.84%.
Market News and Data brought to you by Benzinga APIs
Posted In: Trading IdeasDrug Manufacturers-Other IndustryHighest RevenueMid-Cap
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...